Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases
- Conditions
- Childhood Myelodysplastic SyndromesChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Chronic Myelogenous LeukemiaChronic Phase Chronic Myelogenous Leukemiade Novo Myelodysplastic SyndromesPreviously Treated Myelodysplastic SyndromesChildhood Acute Myeloid Leukemia in RemissionJuvenile Myelomonocytic LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaSecondary Myelodysplastic Syndromes
- Interventions
- First Posted Date
- 2007-03-22
- Last Posted Date
- 2022-04-28
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 27
- Registration Number
- NCT00450450
- Locations
- 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
🇺🇸Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Childrens Memorial Hospital, Chicago, Illinois, United States
Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging
- First Posted Date
- 2007-03-09
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 97
- Registration Number
- NCT00445718
- Locations
- 🇺🇸
Rainbow Babies and Childrens Hospital, Cleveland, Ohio, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment
- Conditions
- Interventions
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2019-07-17
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 92
- Registration Number
- NCT00436852
- Locations
- 🇺🇸
Cook Children's Medical Center, Fort Worth, Texas, United States
🇺🇸Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
🇺🇸Oregon Health and Science University, Portland, Oregon, United States
Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2018-08-07
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 9350
- Registration Number
- NCT00436696
- Locations
- 🇺🇸
Childrens Oncology Group, Philadelphia, Pennsylvania, United States
🇺🇸University of Mississippi Medical Center, Jackson, Mississippi, United States
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
- Conditions
- Interventions
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2017-07-21
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 233
- Registration Number
- NCT00437060
- Locations
- 🇺🇸
Children's Hospital Central California, Madera, California, United States
🇺🇸Nationwide Children's Hospital, Columbus, Ohio, United States
🇺🇸Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Registration and Informed Consent Study for the Childhood Cancer Research Network
- Conditions
- Interventions
- First Posted Date
- 2007-02-12
- Last Posted Date
- 2013-06-27
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 2242
- Registration Number
- NCT00433394
- Locations
- 🇺🇸
Jonathan Jaques Children's Cancer Center at Miller Children's Hospital, Long Beach, California, United States
🇺🇸Mission Hospitals - Memorial Campus, Asheville, North Carolina, United States
🇺🇸Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center, Farmington, Connecticut, United States
Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder
- First Posted Date
- 2006-12-13
- Last Posted Date
- 2015-09-30
- Lead Sponsor
- Children's Oncology Group
- Registration Number
- NCT00411281
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET
- Conditions
- Interventions
- First Posted Date
- 2006-10-26
- Last Posted Date
- 2024-01-26
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 379
- Registration Number
- NCT00392327
- Locations
- 🇺🇸
Inova Fairfax Hospital, Falls Church, Virginia, United States
🇺🇸Bronson Methodist Hospital, Kalamazoo, Michigan, United States
🇵🇷University Pediatric Hospital, San Juan, Puerto Rico
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
- Conditions
- Interventions
- First Posted Date
- 2006-09-28
- Last Posted Date
- 2019-08-07
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 146
- Registration Number
- NCT00382109
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇨🇦Hospital for Sick Children, Toronto, Ontario, Canada
🇺🇸Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
- Conditions
- Interventions
- First Posted Date
- 2006-09-28
- Last Posted Date
- 2024-03-26
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 275
- Registration Number
- NCT00381680
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, United States
🇺🇸Childrens Memorial Hospital, Chicago, Illinois, United States